Kooth provides online mental health and wellbeing support, chiefly to children and young people. Its services include text-based counselling, peer support communities and self-help content, commissioned in the UK mainly by NHS and public sector bodies. In the United States, the company operates the …
IXICO analyses brain imaging data for pharmaceutical and biotechnology companies runningClinical Trialsin neurological diseases. Its services help sponsors measure how experimental treatments affect the brain, using medical images such as MRI scans. The company's proprietary technology platform, known as IXI, applies automated and AI-driven …
ImmuPharma is an AIM-quoted specialist biopharmaceutical business. Its lead asset is P140, also known as Lupuzor or forigerimod, which it is developing as a treatment for autoimmune disease, notably lupus. The company is also developing Kapiglucagon, a proprietary glucagon prodrug aimed mainly at dual-hormone …
hVIVO runs human challenge clinical trials, in which volunteers are deliberately exposed to infectious agents under controlled conditions to test vaccines and antiviral treatments. It operates aQuarantineFacilityin Canary Wharf, provides laboratory services including virology and molecular testing, and offers site and recruitment support for …
Inspiration Healthcare develops, manufactures and supplies medical technology, with a particular emphasis on products used in the care of newborn babies, such as equipment for neonatal intensive care units. It sells to hospitals in the UK, including within the NHS, and to customers internationally. …
Fusion Antibodies Plc (LSE:FAB) is shown up 3.58% for the 8 October 2026 trading reference supplied for this report.
GENinCode PLC (LSE:GENI) is shown up 3.20% for the 8 October 2026 trading reference supplied for this report.
Oxford Nanopore Technologies Plc (LSE:ONT) is down 3.26% in the 8 October 2026 trading figures. The decline puts near-term sentiment and valuation in focus, but a daily price change alone does not establish its cause.
PolarCapitalGlobal Healthcare Trust plc (LSE:PCGH) is down 1.99% in the 8 October 2026 trading figures. The decline puts near-term sentiment and valuation in focus, but a daily price change alone does not establish its cause.
The market focus is biotechnology portfolio valuations and funding sentiment.